BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
DRD2
,
G-protein-coupled receptor binding
,
Hepatitis
,
Heart
,
Fluoxetine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
therapeutic chelation
Summary
General Info
Curated Studies
Most Correlated Studies
Liver Pharmacology and Xenobiotic Response Repertoire
Liver, breast and endometrial cell lines exposed to 34 toxicological compounds
Lung cancer A549 cells treated with lipocalin 2, enterobactin, and ferric ammonium citrate
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
HL-60 acute myeloid leukemia cells treated with potential differentiation inducing compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Improvement in hematopoiesis after iron chelation therapy with deferasirox in patients with aplastic…
Lead toxicosis of captive vultures: case description and responses to chelation therapy.
The proceedings of the 20th International Conference on Chelation held in the USA: advances on new a…
Combined chelation therapy with deferasirox and deferoxamine in thalassemia.
Iron chelation therapy as a treatment for Pythium insidiosum in an animal model.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease
A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficie…
Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy
Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron O…
Iron Chelation in the Prevention of Secondary Degeneration After Stroke
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ